Ebrahimi, Ramin

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Bekker, L.-G., Das, M., Abdool Karim, Q., Ahmed, K., Batting, J., Brumskine, W., Gill, K., Harkoo, I., Jaggernath, M., Kigozi, G., et al. (2024) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 523

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER) primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Mayer, K. H., Molina, J.-M., Thompson, M. A., Anderson, P. L., Mounzer, K. C., De Wet, J. J., DeJesus, E., Jessen, H., Grant, R. M., Ruane, P. J., et al. (2020) · The Lancet

HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatment

Cited by 428

Post-traumatic Stress Disorder, Coronary Atherosclerosis, and Mortality

Ahmadi, N., Hajsadeghi, F., Mirshkarlo, H. B., Budoff, M., Yehuda, R., & Ebrahimi, R. (2011) · The American Journal of Cardiology

Cardiac Health and Mental HealthPosttraumatic Stress Disorder Research

Cited by 257

Association of subclinical hypothyroidism and cardiovascular disease with mortality

Inoue, K., Ritz, B., Brent, G. A., Ebrahimi, R., Rhee, C. M., & Leung, A. M. (2020) · JAMA Network Open

Thyroid Disorders and TreatmentsThyroid and Parathyroid Surgery

Cited by 191